Treatment IND in Oman
How the treatment ind pathway operates in Oman.
About Treatment IND
US FDA treatment Investigational New Drug category.
How Treatment IND works in Oman
Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.
Patients in Oman seeking access under Treatment IND typically follow this flow: a licensed physician in Oman issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Oman
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.